Biogen Balance Sheet Health
Financial Health criteria checks 5/6
Biogen has a total shareholder equity of $15.9B and total debt of $6.3B, which brings its debt-to-equity ratio to 39.6%. Its total assets and total liabilities are $26.8B and $10.9B respectively. Biogen's EBIT is $2.2B making its interest coverage ratio 19.9. It has cash and short-term investments of $1.9B.
Key information
39.6%
Debt to equity ratio
US$6.29b
Debt
| Interest coverage ratio | 19.9x |
| Cash | US$1.91b |
| Equity | US$15.89b |
| Total liabilities | US$10.92b |
| Total assets | US$26.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIIB's short term assets ($7.1B) exceed its short term liabilities ($3.1B).
Long Term Liabilities: BIIB's short term assets ($7.1B) do not cover its long term liabilities ($7.8B).
Debt to Equity History and Analysis
Debt Level: BIIB's net debt to equity ratio (27.6%) is considered satisfactory.
Reducing Debt: BIIB's debt to equity ratio has reduced from 45.9% to 39.6% over the past 5 years.
Debt Coverage: BIIB's debt is well covered by operating cash flow (28.4%).
Interest Coverage: BIIB's interest payments on its debt are well covered by EBIT (19.9x coverage).